Indrajit Choudhuri is a Cardiology physician. OpenAlex indexes 67 publications with 744 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant
Sponsor: Abbott Medical Devices
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202513 payments
- Boston Scientific CorporationProgram year20253 payments
- Biosense Webster, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.9%Antiarrhythmic36.6%Flecainide Acetate70%Amiodarone Hcl30%Part D≥64 patientsBeta blocker20.7%Metoprolol Succinate57%Carvedilol24%Metoprolol Tartrate11%Sotalol9%Part D<11 patients+ 7 more classes in this area
Blood & clotting
20.2%Factor Xa inhibitor20.2%Eliquis89%Xarelto12%Part D<11 patientsHormonal (systemic)
1.6%Mineralocorticoids1.6%Fludrocortisone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Type A Aortic Dissection Causing Acute Liver Failure: A Rare Vascular Cause of Hepatic Ischemia
American Journal of Respiratory and Critical Care Medicine
2025 - POS0274 PROGNOSTIC SIGNIFICANCE OF 1-YEAR PULMONARY FUNCTION CHANGES IN MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
Annals of the Rheumatic Diseases
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”